Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia1
Michael E. Williams, J. Densmore, Andrew W. Pawluczkowycz, P. V. Beum +5 more
2006Journal of Immunology162 citations Open access
Semantic Scholar

